Exercise PhysiologyNCT03569566
Performance Determinants Factors in Elite Endurance Athletes.
An observational study of Exercise Physiology, run by University of South-Eastern Norway at 1 site in Norway.
Trial summary
Several studies have investigated determinant factors for endurance performance among different athletes, untrained individuals and patients focusing on the impact of age, genes and training intensity. Read more about this study
- Who is it for?
- Ages 16 to 50 yearsHealthy volunteers can take part
- Conditions the study is for
- Exercise Physiology
- What is being tested?
- Age, Genes, Training, Tickbourne Disease and Endurance
- How many people
- 54 participants
- Where
- 1 siteNorway
- Study dates
- 27 Jun 2018to 31 Dec 2021
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 16 to 50 years
- All sexes
- Healthy volunteers accepted
- Child, Adult
Study population: Cross-country skiers at high national or international level
Who may be able to join
- age between 16 and 50
- active competition athletes competing on a national level or above
- athletes who write training diaries
Who cannot join
- Sickness and/or injury who contra indicates normal training and maximal testing.
- An on-going infection or injury.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: The Impact of Age, Genes, Training and History of Tickbourne Disease on Endurance Performance in Elite Endurance Athletes.
Several studies have investigated determinant factors for endurance performance among different athletes, untrained individuals and patients focusing on the impact of age, genes and training intensity. A further step in this research will be to investigate the impact of age, genes, training intensity and history of tick-bourne disease on endurance performance in elite endurance athletes. We are planning a project with a two-step model. In step one we will, in a cross-sectional study design, investigate potential relationships between age, training intensity, training volume, genes, exosomes and history of tick-bourne disease and physiological variables and endurance performance. In step two we will investigate differences in training adaptation by observing and monitoring all training done by the participants during a 6-months period. The participants will be tested for several physiological variables before, after 3- months and after this period. We will also investigate the impact of age, training intensity, training volume, genes and history of tick-bourne disease on the results from the physiological tests and performance.
Read the detailed description
The study will be designed in a two-step model. In the first step, we will investigate potential relationships between age, genes, exosomes, miRNA, training intensity, and history of tick-borne disease, and physiological laboratory-tests and performance in a roller-skiing performance test. This study will have a cross-sectional design. In the second step we will examine potential differences in training adaptations to a 6-months observation of self-selected training. We then will categorize the athletes into three groups, based on training volume and training intensity. We will then investigate possible relationships between training volume and training intensity and physiological variables, genes, age and possible history of tick-bourne disease.
STEP 1: Cross-sectional study:
Since the aim of the study is to investigate effects of age, genes, exosomes, training and history of tick-borne disease on training adaptations and endurance performance in elite endurance athletes, we will recruit active cross-country skiers from 16 - 50 years. These athletes have shown to have some of the highest aerobic capacities in the world (Ingjer, 1991).
Both males and females will be included for participation in this project, and we will try to include equal amount of both sexes. The athletes will be recruited from relevant, cross-country skiing milieus in Southeast Norway by open invitation and advertisement. Invited athletes must sign a declaration for participation and a declaration of health status, before participation. In the declaration for participation, the athletes will be informed briefly about the background of this project, which tests they are going to take, and how these tests will be performed and how the results are being contained and presented.
Statistical analysis will be as descriptive statistics, and simple and multiple regressions- and correlation analysis in the cross-sectional study.
STEP 2: 6-months training observation:
Recruitment routines, inclusion- and exclusion criteria will be the same as in STEP 1.
The athletes will first undergo a week of testing and registration (like STEP 1) at the end of the competitive season. During the 6-months period, the athletes will register all normal training in training diaries, and most importantly by use of heart rate measures. The researchers will not assign the participants to a certain training program or intervention, but just observe and register their training already planned out by themselves and/or their trainer(s). We will then examine the effects of this training on physiological variables and cross-country skiing performance
The first tests will include the following:
- physiological determinants as described in Støren et al. (2012; 2013; 2014) and Sunde et al. (in progress)
- blood samples for the analyze of genes, types of exosomes and its cargo, miRNA and history of tick-borne disease The same tests will be used after 3 months into the training period, and post observation. Tests and test procedures will be specified later.
Statistical analysis will be as descriptive statistics, hypothesis testing as General Linear Models ANOVA (repeated measurements), and simple- and multiple regressions- and correlation analysis to examine increase or decrease in relation to age, gender, physical capacity and genes.
Tests and test procedures:
The same test procedures will be followed in both STEP 1 and STEP 2 of the project, and pre-, mid- and post-test. All tests will be executed in two following days.
Day 1:
- Registration of body weight, body height and BMI, and blood samples for exosomes, genes and tick-borne disease
- Maximal jump tests (SJ, CMJ and CMJas)
- VO2max test in running, followed by blood samples for exosomes
- Performance field-test in roller skiing
Day 2:
- LT-test and energy cost of double poling (Cp)
- VO2peak in double poling
- Blood samples for exosomes
- 1RM half-squat, followed by blood samples for exosomes
- 1RM pull down
DAY 1:
When the athletes arrives, body weight and body height will be measured. Blood samples will be taken for analysis of exosomes, genes and tick-borne disease.
Blood samples and genetic analysis To examine the effects of exosomes, genes and history of tick-borne disease on training adaptation and endurance performance among elite endurance athletes, it will be necessary to gather blood samples for examination of genetic variation, exosome cargo, exosome content and antibodies for tick-borne diseases.
The field, Exercise Genomics, explore the variation in single candidate genes relation to physiological responses to exercise in a population. Therefore, it is relevant to apply research on genes relation to training adaptations and human endurance performance, but also in relation to health-related physical activity. We also want to analyze volume and types of exosomes in response to training, with a focus on content of miRNA, proteins and/or DNA as biological markers for physiological training response.
In this research project we need blood samples from recruited cross-country skiers to examine genetic variations, which have been related to cause an effect on physiological responses like fat oxidation, glucose utilization, insulin sensitivity, muscle hypertrophy, VO2max and blood pressure. The exosomes will be isolated from plasma by an ultracentrifugation method.
Blood samples for analysis of biological markers We want blood samples (EDTA-blood) from all participants. Blood samples will be taken in relation to the training interventions, and will be used for DNA isolation, DNA analysis, exosome isolation from plasma and isolation of antibodies from plasma.
Jumping variables (SJ, CMJ, CMJas):
After arrival and registration of body weight and body height, the athletes will be instructed to perform a 10-minutes self-conducted warm-up before testing. For measuring jump height, we will use a force plate and the Muscle Lab v.2 system (Ergotest Technology, Langesund, Norway) The first jump procedure will be by measuring squat jump (SJ) height. The subjects' starts with a 90° knee angle, with a forward leaned position and with their hands attached to the hips. The subjects' will then jump with maximal force, without any counter movement in the knees or hips. The subjects perform minimum three and maximum six jump with maximal force, where the highest jump will be registered as the result.
After this, the subjects will perform the second jumping procedure, who will be the counter-movement jump (CMJ). The athletes start in an upright position with their hands attached to the hips. They will thereafter perform a maximal jump with plyometric movement. The subjects perform minimum three and maximum six jump with maximal force, where the highest jump will be registered as the result.
The last jump procedure is the counter movement jump with arm movement. The subjects starts in the position like CMJ, but are now allowed to use the arms. They will be instructed to perform a jump with maximal force. The subjects perform minimum three and maximum six jump with maximal force, where the highest jump will be registered as the result.
The subjects' are given three minutes rest between each jumping procedure.
VO2max in running:
The test will be performed on a motorized Woodway PPS55-treadmill (Waukesha, WI, USA), calibrated for elevation and speed. A Cortex MetaLyzer II (Cortex Biophysik GmbH, Leipzig, Germany) measures VO2 every 10 s through the test. The subjects' will be instructed to perform a 10-minutes self-conducted warm-up before testing.
The test starts at 8 - 12 km/h, and a 6% elevation. A 1% elevation increase will be performed up to 8%. From there, only speed increases with 0,5 km/h every 30 second until voluntary exhaustion.
Contra indications during testing will end the test. The participants are allowed to stop the test at any given time.
To evaluate if VO2max is reached, we will use the following criteria: flattening of the O2-curve, RER > 1.05, 3 - 5 beats under the athlete's maximal heart rate (HRmax), Borg scale > 16 and blood lactate levels > 8.0 mmol/l.
Time-trial performance test on roller skies The participants will be instructed to perform a minimum 15 minutes self-conducted warm-up before test. They will use their own roller-skiing equipment during this test. Before testing, the athletes will be informed to use Swenor 2-wheels, or equal, during this test to prevent any differences in rolling resistance.
During this test, the athletes participate in randomly assigned pairs, with a 1-minute start interval between subjects. They will perform six laps of 940 meters, as fast as they can, using only the double-poling technique. No drafting is allowed. Stopwatches register performance time.
The total time used in this time-trial will be used as result from this test. Heart rate will be monitored by the athletes private watches, and registered immediately after finish.
DAY 2:
Lactate threshold (LT) og cost of poling (Cp) during double-poling The test will be performed on a Rodby RL2500E - treadmill with rubber belts (Rodby Innovation, Vänge, Sweden), special made for double poling. The participants will perform a minimum 10 minutes self-conducted warm-up before testing, and for familiarization to the treadmill.
Lactate, VO2 and RER will be measured during several 4-minute submaximal work periods (minimum 3 and maximum 6) at 4% inclination. All the athletes will use the same roller-skies, but they will use their own poles and shoes during the test. The procedure for this test will be as follows:
- Work period 1: The workload will represent approximately 60% HRmax. The speed of the treadmill will be set to 11.5 km/h and 6 - 7 km/h for males and females respectively, and will be held constant through the 4-minute work period. After 4 minutes, the treadmill stops and lactate measuring will be proceeded.
- Work period 2, 3 and 4 (eventually 5 and 6): The speed will increase progressively (evaluated by research-personal) through the work periods, until blood lactate exceeds estimated LT-values (LT = warm-up lactate value (taken after the first work period) + 2,3 mmol/l).
- HR and VO2 will be measured every 20 second from the 3.00 minute point in every work period (3.00 / 3.20 / 3.40).
Blood lactate is measured by a Lactate Scout+ apparatus (Senslab, EKF Diagnostics, Germany), which is based on whole blood analysis.
Contra indications during testing will end the test. The participants are allowed to stop the test at any given time.
Registration of VO2 during the work periods are later used for calculations of Cp at 70% Vo2max.
VO2peak double poling The test will be performed at least 5 minutes after the LT-test on the same treadmill specialized for double poling. All the athletes will use the same roller-skies, but they will use their own poles and shoes during the test. VO2, HR and RER will be measured continuously during this test.
The test will proceed as follows:
- The speed is set to 7 km/h for both males and females, at a 6 % inclination and is held constant through the whole test.
- The speed progressively increase by 1 km/h every minute for males and females, until exhaustion.
The three continuously highest VO2 measures will be used for calculation of VO2max. The test will be followed by registration of blood lactate (as described earlier), Borg scale, RERpeak and HRpeak.
1RM half squat:
For this test, a Precor smith-machine (Precore, Woodinville, WA, USA) will be used. The athletes will be given at least 60 minutes rest between last test, and this test. The participants will follow a standardized warm-up procedure as follows:
- 10 repetions à 50% 1RM,
- 5 repetions à 60% av 1RM,
- 3 repetions à 70% av 1RM
- 2 repetions à 80% av 1RM. A 3-minute rest period will be given between every work period. The participants will be instructed to lift with maximal speed from the first workload, for measuring muscle power. MuscleLab v. 2 (Ergotest Technology, Langesund, Norway) will measure power during the test.
After the standardized warm-up, the workload will increase progressively until 1RM is reached. In this part of the test, the participants only perform one repetion pr. workload.
1RM pull down: A Gym2000 pull-down machine (Gym2000 AS, Vikersund, Norway) will be used for this test. The protocol for this test is identical to the 1RM half-squat protocol.
- Conditions
- Exercise Physiology
- Being tested
- Age, Genes, Training, Tickbourne Disease and Endurance
- Keywords
- Age, Genes, Training volume, Training intensity, Tick-bourne disease, Endurance performance, Elite endurance athletes
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Age, Genes, Training, Tickbourne Disease and EnduranceOther
Testing of genes, exosomes, physiological variables, tick-bourne disease markers, observation of training modality and performance
| Study group | Role | What they receive |
|---|---|---|
| Elite endurance athletes | Cross-country skiers at high national level Receives: Other: Age, Genes, Training, Tickbourne Disease and Endurance |
What is being measured
The primary outcome is the main question the study is designed to answer.
Time trail cross-country roller skiing performance
Testing of seconds used in a predefined track
Measured: Change from baseline performance at 3-months and at 6-months
Maximal oxygen consumption
Standard ergospirometrical incremental test in running and double-poling
Measured: Change from baseline maximal oxygen uptake at 3-months and at 6-months
Secondary outcomes (11)
Lactate threshold in double poling
Onset of blood lactate accumulation in an incremental interval protocol
Measured: Change from baseline lactate threshold at 3-months and at 6-months
Double poling economy
Ergospirometrical measurement of oxygen consumption per meter poling
Measured: Change from baseline economy at 3-months and at 6-months
Maximal strength
Kilograms measured in one repetition maximum in half-squat and pull-down
Measured: Change from baseline maximal strength at 3-months and at 6-months
Jump height
Centimeters measured on force platform in squat jump, counter movement jump and countermovement jump with armswing
Measured: Change from baseline jump height at 3-months and at 6-months
Genotypes
Distribution of alleles for candidate genes derrived from blood samples
Measured: Baseline
Tick-bourne disease
Blood markers for previous tick-bourne disease
Measured: Baseline
Exosomes
Quantifying number of exosomes in blood immediately before and after maximal aerobic work and maximal strength tests
Measured: Baseline
Training volume
Registration of training volume in hours from training diaries
Measured: Change from baseline training volume at 3-months and at 6-months
Training intensity
Registration of training intensity by use of heart rate measures corresponding to the training intensity scale made by the Norwegian Olympic Sports Center.
Measured: Change from baseline training intensity at 3-months and at 6-months
Age
Age in years
Measured: Baseline
Maximal power
Maximal power in watt in half-squat and pull-down
Measured: Change from baseline power at 3-months and at 6-months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 Jun 2018
- Study start27 Jun 2018
- Primary completion31 Dec 2021
- Study completion31 Dec 2021
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (4)Papers the sponsor has linked to this study.
- Other trials for Exercise PhysiologyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Enrolment
- 54 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of South-Eastern Norway
- Sponsor type
- University, hospital or other
- Collaborators
- Norwegian University of Science and Technology
- Responsible party
- Sponsor
- Investigators
- Pål Augestad, PhD, Study chair, University of South-Eastern Norway
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03569566
- Sponsor's protocol ID
- 2017/2522
- Status last verified
- Dec 2021
- First submitted
- 28 May 2018
- Last updated
- 4 Aug 2022
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Storen O, Bratland-Sanda S, Haave M, Helgerud J. Improved VO2max and time trial performance with more high aerobic intensity interval training and reduced training volume: a case study on an elite national cyclist. J Strength Cond Res. 2012 Oct;26(10):2705-11. doi: 10.1519/JSC.0b013e318241deec.
PubMed 22124353Ingjer, F. Maximal oxygen uptake as a predictor of performance ability in women and men elite cross-country skiers. Scand. J. Med. Sci. Sports. 1: 25-30, 1991.
Storen O, Ulevag K, Larsen MH, Stoa EM, Helgerud J. Physiological determinants of the cycling time trial. J Strength Cond Res. 2013 Sep;27(9):2366-73. doi: 10.1519/JSC.0b013e31827f5427.
PubMed 23238091Storen O, Ronnestad BR, Sunde A, Hansen J, Ellefsen S, Helgerud J. A time-saving method to assess power output at lactate threshold in well-trained and elite cyclists. J Strength Cond Res. 2014 Mar;28(3):622-9. doi: 10.1519/JSC.0b013e3182a73e70.
PubMed 23942166
Study at a glance
From the registry record, last updated by the sponsor on 4 Aug 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Impact of Age, Genes, Training and History of Tickbourne Disease on Endurance Performance in Elite Endurance Athletes.
- ClinicalTrials.gov ID
- NCT03569566
- Acronym / sponsor ID
- 2017/2522
- Conditions
- Exercise Physiology
- Keywords
- Age, Genes, Training volume, Training intensity, Tick-bourne disease, Endurance performance, Elite endurance athletes
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 54 participants (actual)
- Lead sponsor
- University of South-Eastern NorwayUniversity, hospital or other
- Collaborators
- Norwegian University of Science and Technology
- Study start
- 27 Jun 2018 (actual)
- Primary completion
- 31 Dec 2021 (actual)
- Study completion
- 31 Dec 2021 (actual)
- First posted
- 26 Jun 2018 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Several studies have investigated determinant factors for endurance performance among different athletes, untrained individuals and patients focusing on the impact of age, genes and training intensity. A further step in this research will be to investigate the impact of age, genes, training intensity and history of tick-bourne disease on endurance performance in elite endurance athletes. We are planning a project with a two-step model. In step one we will, in a cross-sectional study design, investigate potential relationships between age, training intensity, training volume, genes, exosomes and history of tick-bourne disease and physiological variables and endurance performance. In step two we will investigate differences in training adaptation by observing and monitoring all training done by the participants during a 6-months period. The participants will be tested for several physiological variables before, after 3- months and after this period. We will also investigate the impact of age, training intensity, training volume, genes and history of tick-bourne disease on the results from the physiological tests and performance.
Detailed description
The study will be designed in a two-step model. In the first step, we will investigate potential relationships between age, genes, exosomes, miRNA, training intensity, and history of tick-borne disease, and physiological laboratory-tests and performance in a roller-skiing performance test. This study will have a cross-sectional design. In the second step we will examine potential differences in training adaptations to a 6-months observation of self-selected training. We then will categorize the athletes into three groups, based on training volume and training intensity. We will then investigate possible relationships between training volume and training intensity and physiological variables, genes, age and possible history of tick-bourne disease.
STEP 1: Cross-sectional study:
Since the aim of the study is to investigate effects of age, genes, exosomes, training and history of tick-borne disease on training adaptations and endurance performance in elite endurance athletes, we will recruit active cross-country skiers from 16 - 50 years. These athletes have shown to have some of the highest aerobic capacities in the world (Ingjer, 1991).
Both males and females will be included for participation in this project, and we will try to include equal amount of both sexes. The athletes will be recruited from relevant, cross-country skiing milieus in Southeast Norway by open invitation and advertisement. Invited athletes must sign a declaration for participation and a declaration of health status, before participation. In the declaration for participation, the athletes will be informed briefly about the background of this project, which tests they are going to take, and how these tests will be performed and how the results are being contained and presented.
Statistical analysis will be as descriptive statistics, and simple and multiple regressions- and correlation analysis in the cross-sectional study.
STEP 2: 6-months training observation:
Recruitment routines, inclusion- and exclusion criteria will be the same as in STEP 1.
The athletes will first undergo a week of testing and registration (like STEP 1) at the end of the competitive season. During the 6-months period, the athletes will register all normal training in training diaries, and most importantly by use of heart rate measures. The researchers will not assign the participants to a certain training program or intervention, but just observe and register their training already planned out by themselves and/or their trainer(s). We will then examine the effects of this training on physiological variables and cross-country skiing performance
The first tests will include the following:
- physiological determinants as described in Støren et al. (2012; 2013; 2014) and Sunde et al. (in progress)
- blood samples for the analyze of genes, types of exosomes and its cargo, miRNA and history of tick-borne disease The same tests will be used after 3 months into the training period, and post observation. Tests and test procedures will be specified later.
Statistical analysis will be as descriptive statistics, hypothesis testing as General Linear Models ANOVA (repeated measurements), and simple- and multiple regressions- and correlation analysis to examine increase or decrease in relation to age, gender, physical capacity and genes.
Tests and test procedures:
The same test procedures will be followed in both STEP 1 and STEP 2 of the project, and pre-, mid- and post-test. All tests will be executed in two following days.
Day 1:
- Registration of body weight, body height and BMI, and blood samples for exosomes, genes and tick-borne disease
- Maximal jump tests (SJ, CMJ and CMJas)
- VO2max test in running, followed by blood samples for exosomes
- Performance field-test in roller skiing
Day 2:
- LT-test and energy cost of double poling (Cp)
- VO2peak in double poling
- Blood samples for exosomes
- 1RM half-squat, followed by blood samples for exosomes
- 1RM pull down
DAY 1:
When the athletes arrives, body weight and body height will be measured. Blood samples will be taken for analysis of exosomes, genes and tick-borne disease.
Blood samples and genetic analysis To examine the effects of exosomes, genes and history of tick-borne disease on training adaptation and endurance performance among elite endurance athletes, it will be necessary to gather blood samples for examination of genetic variation, exosome cargo, exosome content and antibodies for tick-borne diseases.
The field, Exercise Genomics, explore the variation in single candidate genes relation to physiological responses to exercise in a population. Therefore, it is relevant to apply research on genes relation to training adaptations and human endurance performance, but also in relation to health-related physical activity. We also want to analyze volume and types of exosomes in response to training, with a focus on content of miRNA, proteins and/or DNA as biological markers for physiological training response.
In this research project we need blood samples from recruited cross-country skiers to examine genetic variations, which have been related to cause an effect on physiological responses like fat oxidation, glucose utilization, insulin sensitivity, muscle hypertrophy, VO2max and blood pressure. The exosomes will be isolated from plasma by an ultracentrifugation method.
Blood samples for analysis of biological markers We want blood samples (EDTA-blood) from all participants. Blood samples will be taken in relation to the training interventions, and will be used for DNA isolation, DNA analysis, exosome isolation from plasma and isolation of antibodies from plasma.
Jumping variables (SJ, CMJ, CMJas):
After arrival and registration of body weight and body height, the athletes will be instructed to perform a 10-minutes self-conducted warm-up before testing. For measuring jump height, we will use a force plate and the Muscle Lab v.2 system (Ergotest Technology, Langesund, Norway) The first jump procedure will be by measuring squat jump (SJ) height. The subjects' starts with a 90° knee angle, with a forward leaned position and with their hands attached to the hips. The subjects' will then jump with maximal force, without any counter movement in the knees or hips. The subjects perform minimum three and maximum six jump with maximal force, where the highest jump will be registered as the result.
After this, the subjects will perform the second jumping procedure, who will be the counter-movement jump (CMJ). The athletes start in an upright position with their hands attached to the hips. They will thereafter perform a maximal jump with plyometric movement. The subjects perform minimum three and maximum six jump with maximal force, where the highest jump will be registered as the result.
The last jump procedure is the counter movement jump with arm movement. The subjects starts in the position like CMJ, but are now allowed to use the arms. They will be instructed to perform a jump with maximal force. The subjects perform minimum three and maximum six jump with maximal force, where the highest jump will be registered as the result.
The subjects' are given three minutes rest between each jumping procedure.
VO2max in running:
The test will be performed on a motorized Woodway PPS55-treadmill (Waukesha, WI, USA), calibrated for elevation and speed. A Cortex MetaLyzer II (Cortex Biophysik GmbH, Leipzig, Germany) measures VO2 every 10 s through the test. The subjects' will be instructed to perform a 10-minutes self-conducted warm-up before testing.
The test starts at 8 - 12 km/h, and a 6% elevation. A 1% elevation increase will be performed up to 8%. From there, only speed increases with 0,5 km/h every 30 second until voluntary exhaustion.
Contra indications during testing will end the test. The participants are allowed to stop the test at any given time.
To evaluate if VO2max is reached, we will use the following criteria: flattening of the O2-curve, RER > 1.05, 3 - 5 beats under the athlete's maximal heart rate (HRmax), Borg scale > 16 and blood lactate levels > 8.0 mmol/l.
Time-trial performance test on roller skies The participants will be instructed to perform a minimum 15 minutes self-conducted warm-up before test. They will use their own roller-skiing equipment during this test. Before testing, the athletes will be informed to use Swenor 2-wheels, or equal, during this test to prevent any differences in rolling resistance.
During this test, the athletes participate in randomly assigned pairs, with a 1-minute start interval between subjects. They will perform six laps of 940 meters, as fast as they can, using only the double-poling technique. No drafting is allowed. Stopwatches register performance time.
The total time used in this time-trial will be used as result from this test. Heart rate will be monitored by the athletes private watches, and registered immediately after finish.
DAY 2:
Lactate threshold (LT) og cost of poling (Cp) during double-poling The test will be performed on a Rodby RL2500E - treadmill with rubber belts (Rodby Innovation, Vänge, Sweden), special made for double poling. The participants will perform a minimum 10 minutes self-conducted warm-up before testing, and for familiarization to the treadmill.
Lactate, VO2 and RER will be measured during several 4-minute submaximal work periods (minimum 3 and maximum 6) at 4% inclination. All the athletes will use the same roller-skies, but they will use their own poles and shoes during the test. The procedure for this test will be as follows:
- Work period 1: The workload will represent approximately 60% HRmax. The speed of the treadmill will be set to 11.5 km/h and 6 - 7 km/h for males and females respectively, and will be held constant through the 4-minute work period. After 4 minutes, the treadmill stops and lactate measuring will be proceeded.
- Work period 2, 3 and 4 (eventually 5 and 6): The speed will increase progressively (evaluated by research-personal) through the work periods, until blood lactate exceeds estimated LT-values (LT = warm-up lactate value (taken after the first work period) + 2,3 mmol/l).
- HR and VO2 will be measured every 20 second from the 3.00 minute point in every work period (3.00 / 3.20 / 3.40).
Blood lactate is measured by a Lactate Scout+ apparatus (Senslab, EKF Diagnostics, Germany), which is based on whole blood analysis.
Contra indications during testing will end the test. The participants are allowed to stop the test at any given time.
Registration of VO2 during the work periods are later used for calculations of Cp at 70% Vo2max.
VO2peak double poling The test will be performed at least 5 minutes after the LT-test on the same treadmill specialized for double poling. All the athletes will use the same roller-skies, but they will use their own poles and shoes during the test. VO2, HR and RER will be measured continuously during this test.
The test will proceed as follows:
- The speed is set to 7 km/h for both males and females, at a 6 % inclination and is held constant through the whole test.
- The speed progressively increase by 1 km/h every minute for males and females, until exhaustion.
The three continuously highest VO2 measures will be used for calculation of VO2max. The test will be followed by registration of blood lactate (as described earlier), Borg scale, RERpeak and HRpeak.
1RM half squat:
For this test, a Precor smith-machine (Precore, Woodinville, WA, USA) will be used. The athletes will be given at least 60 minutes rest between last test, and this test. The participants will follow a standardized warm-up procedure as follows:
- 10 repetions à 50% 1RM,
- 5 repetions à 60% av 1RM,
- 3 repetions à 70% av 1RM
- 2 repetions à 80% av 1RM. A 3-minute rest period will be given between every work period. The participants will be instructed to lift with maximal speed from the first workload, for measuring muscle power. MuscleLab v. 2 (Ergotest Technology, Langesund, Norway) will measure power during the test.
After the standardized warm-up, the workload will increase progressively until 1RM is reached. In this part of the test, the participants only perform one repetion pr. workload.
1RM pull down: A Gym2000 pull-down machine (Gym2000 AS, Vikersund, Norway) will be used for this test. The protocol for this test is identical to the 1RM half-squat protocol.
Study design
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Elite endurance athletes | – | Other: Age, Genes, Training, Tickbourne Disease and EnduranceCross-country skiers at high national level |
Who may qualify
- Ages
- 16 to 50 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult
- Study population
- Cross-country skiers at high national or international level
Key inclusion criteria (3 listed)
- age between 16 and 50
- active competition athletes competing on a national level or above
- athletes who write training diaries
Key exclusion criteria (2 listed)
- Sickness and/or injury who contra indicates normal training and maximal testing.
- An on-going infection or injury.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Age, Genes, Training, Tickbourne Disease and EnduranceTesting of genes, exosomes, physiological variables, tick-bourne disease markers, observation of training modality and performance | Other | Elite endurance athletes |
Primary outcome
Time trail cross-country roller skiing performance
Time frame: Change from baseline performance at 3-months and at 6-months
Testing of seconds used in a predefined track
Maximal oxygen consumption
Time frame: Change from baseline maximal oxygen uptake at 3-months and at 6-months
Standard ergospirometrical incremental test in running and double-poling
11 secondary outcomes
Lactate threshold in double poling
Time frame: Change from baseline lactate threshold at 3-months and at 6-months
Double poling economy
Time frame: Change from baseline economy at 3-months and at 6-months
Maximal strength
Time frame: Change from baseline maximal strength at 3-months and at 6-months
Jump height
Time frame: Change from baseline jump height at 3-months and at 6-months
Genotypes
Time frame: Baseline
Tick-bourne disease
Time frame: Baseline
Exosomes
Time frame: Baseline
Training volume
Time frame: Change from baseline training volume at 3-months and at 6-months
Training intensity
Time frame: Change from baseline training intensity at 3-months and at 6-months
Age
Time frame: Baseline
Maximal power
Time frame: Change from baseline power at 3-months and at 6-months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 4 Aug 2022.
- Background: PubMed 22124353Storen O, Bratland-Sanda S, Haave M, Helgerud J. Improved VO2max and time trial performance with more high aerobic intensity interval training and reduced training volume: a case study on an elite national cyclist. J Strength Cond Res. 2012 Oct;26(10):2705-11. doi: 10.1519/JSC.0b013e318241deec.
- BackgroundIngjer, F. Maximal oxygen uptake as a predictor of performance ability in women and men elite cross-country skiers. Scand. J. Med. Sci. Sports. 1: 25-30, 1991.
- Background: PubMed 23238091Storen O, Ulevag K, Larsen MH, Stoa EM, Helgerud J. Physiological determinants of the cycling time trial. J Strength Cond Res. 2013 Sep;27(9):2366-73. doi: 10.1519/JSC.0b013e31827f5427.
- Background: PubMed 23942166Storen O, Ronnestad BR, Sunde A, Hansen J, Ellefsen S, Helgerud J. A time-saving method to assess power output at lactate threshold in well-trained and elite cyclists. J Strength Cond Res. 2014 Mar;28(3):622-9. doi: 10.1519/JSC.0b013e3182a73e70.
- Individual participant dataSharing planned: No
Related trials for Exercise Physiology
Enrolling by invitation
Online Exercise Program for Transplant Patients: A Pilot Study
Kidney Transplantation, Physical Function
Not yet recruiting
Effect of Box Breathing Exercise on Anxiety, Pain, and Pulmonary Function Tests in Patients Undergoing Colonoscopy
Colonoscopy
Active, not recruiting
Diaphragm Mobilization in Adolescent Idiopathic Scoliosis
Adolescent Idiopathic Scoliosis
Not yet recruitingObservational study
Validation of Uzbek SARC-F and IPAQ-SF Questionnaires in Adults With and Without Hypothyroidism
Hypothyroidism, Psychometrics
Active, not recruiting
All-extremity Exercise During Breast Cancer Chemotherapy
Breast Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Pål Augestad, PhD study chair
University of South-Eastern Norway
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Exercise Physiology, run by University of South-Eastern Norway at 1 site in Norway.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 4 Aug 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Time trail cross-country roller skiing performance (time frame: Change from baseline performance at 3-months and at 6-months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03569566, which also lists 4 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Aug 2022.